Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders

Experimental Gerontology

Volumn 44, Issue 10, 2009, Pages 625-633

  Mattson, Mark P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Atherosclerosis; Diabetes; Insulin resistance; Lipid peroxidation; Metabolic syndrome

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATASE; ALPHA TOCOPHEROL; AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE; AMYLOID; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CARNOSINE; CURCUMIN; DNA; EBSELEN; EXENDIN 4; GLUCOSE TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTATHIONE; HISTIDINE DERIVATIVE; LOW DENSITY LIPOPROTEIN; MANGANESE SUPEROXIDE DISMUTASE; N TERT BUTYL ALPHA PHENYLNITRONE; OXIDOREDUCTASE; PRESENILIN 1; SULFORAPHANE; TAU PROTEIN; TAURINE; THIOCTIC ACID; UBIDECARENONE; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CALORIC INTAKE; CALORIC RESTRICTION; DEGENERATIVE DISEASE; DNA DAMAGE; DRUG EFFICACY; DRUG TARGETING; DYSLIPIDEMIA; EXERCISE; HEART INFARCTION; HUMAN; HUNTINGTON CHOREA; INSULIN RESISTANCE; LIPID PEROXIDATION; LOW CALORY DIET; METABOLIC SYNDROME X; NERVE CELL DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PARKINSON DISEASE; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; STROKE; VASCULAR DISEASE;

ALDEHYDES; CROSS-LINKING REAGENTS; DIET; HUMANS; LIPID PEROXIDATION; METABOLIC SYNDROME X; NEURODEGENERATIVE DISEASES; OBESITY; OXIDATIVE STRESS; VASCULAR DISEASES;

EID: 70349236876     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2009.07.003     Document Type: Review

References (134)

1. Abbate A., Biondi-Zoccai G.G., Bussani R., Dobrina A., Camilot D., Feroce F., Rossiello R., Baldi F., Silvestri F., Biasucci L.M., and Baldi A. Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. J. Am. Coll. Cardiol. 41 (2003) 753-760
2. Adibhatla R.M., Hatcher J.F., and Dempsey R.J. Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. Antioxid. Redox. Signal. 5 (2003) 647-654
3. Adlard P.A., Perreau V.M., Pop V., and Cotman C.W. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J. Neurosci. 25 (2005) 4217-4221
4. Aggoun Y. Obesity, metabolic syndrome, and cardiovascular disease. Pediatr. Res. 61 (2007) 653-659
5. Ahmet I., Wan R., Mattson M.P., Lakatta E.G., and Talan M. Cardioprotection by intermittent fasting in rats. Circulation 112 (2005) 3115-3121
6. Aldini G., Vistoli G., Regazzoni L., Gamberoni L., Facino R.M., Yamaguchi S., Uchida K., and Carini M. Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species?. Chem. Res. Toxicol. 21 (2008) 824-835
7. Aleynik S.I., Leo M.A., Aleynik M.K., and Lieber C.S. Alcohol-induced pancreatic oxidative stress: protection by phospholipid repletion. Free Radic. Biol. Med. 26 (1999) 609-619
8. Annangudi S.P., Deng Y., Gu X., Zhang W., Crabb J.W., and Salomon RG. Low-density lipoprotein has an enormous capacity to bind (E)-4-hydroxynon-2-enal (HNE): detection and characterization of lysyl and histidyl adducts containing multiple molecules of HNE. Chem. Res. Toxicol. 21 (2008) 1384-1395
9. Bakris, G., Stockert, J., Molitch, M., Zhou, Q., Champion, A., Bacher, P., Sowers, J., On behalf of the STAR Investigators. 2008. Risk factor assessment for new onset diabetes: literature review. Diabetes Obes. Metab. 2008 Jun 16 (Epub ahead of print).
10. Barness L.A., Opitz J.M., and Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am. J. Med. Genet. A. 143A (2007) 3016-3034
11. Baydas G., Donder E., Kiliboz M., Sonkaya E., Tuzcu M., Yasar A., and Nedzvetskii V.S. Neuroprotection by alpha-lipoic acid in streptozotocin-induced diabetes. Biochemistry (Mosc). 69 (2004) 1001-1005
12. Benderdour M., Charron G., DeBlois D., Comte B., and Des Rosiers C. Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development. J. Biol. Chem. 278 (2003) 45154-45159
13. Bhatnagar A. Electrophysiological effects of 4-hydroxynonenal, an aldehydic product of lipid peroxidation, on isolated rat ventricular myocytes. Circ. Res. 76 (1995) 293-304
14. Blanc E.M., Kelly J.F., Mark R.J., Waeg G., and Mattson M.P. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G alpha(q/11). J. Neurochem. 69 (1997) 570-580
15. Blasig I.E., Grune T., Schönheit K., Rohde E., Jakstadt M., Haseloff R.F., and Siems W.G. 4-Hydroxynonenal, a novel indicator of lipid peroxidation for reperfusion injury of the myocardium. Am. J. Physiol. 269 (1995) H14-22
16. Boillée S., Vande Velde C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
17. Bruce A.J., Malfroy B., and Baudry M. Beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA 93 (1996) 2312-2316
18. Bruce-Keller A.J., Li Y.J., Lovell M.A., Kraemer P.J., Gary D.S., Brown R.R., Markesbery W.R., and Mattson MP. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J. Neuropathol. Exp. Neurol. 57 (1998) 257-267
19. Butterfield D.A., Hensley K., Harris M., Mattson M., and Carney J. Beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200 (1994) 710-715
20. Camandola S., and Mattson M.P. NF-kappa B as a therapeutic target in neurodegenerative diseases. Expert. Opin. Ther. Targets. 11 (2007) 123-132
21. Cao D., Lu H., Lewis T.L., and Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 282 (2007) 36275-36282
22. Ceradini D.J., Yao D., Grogan R.H., Callaghan M.J., Edelstein D., Brownlee M., and Gurtner G.C. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J. Biol. Chem. 283 (2008) 10930-10938
23. Cersosimo E., and DeFronzo R.A. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab. Res. Rev. 22 (2006) 423-436
24. Chen L., Na R., Gu M., Richardson A., and Ran Q. Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. J. Neurochem. 107 (2008) 197-207
25. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., Carter C., Yu B.P., and Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8 (2009) 18-30
26. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., and Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad. Sci. USA 101 (2004) 2070-2075
27. Dasuri K., Nguyen A., Zhang L., Fernandez-Kim O.S., Bruce-Keller A.J., Blalock B.A., Cabo R.D., and Keller J.N. Comparison of rat liver and brain proteasomes for oxidative stress-induced inactivation: influence of ageing and dietary restriction. Free Radic. Res. 43 (2009) 28-36
28. Devaraj S., Wang-Polagruto J., Polagruto J., Keen C.L., and Jialal I. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 57 (2008) 867-870
29. El Midaoui A., Ismael M.A., Lu H., Fantus I.G., de Champlain J., and Couture R. Comparative effects of N-acetyl-l-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats. Can. J. Physiol. Pharmacol. 86 (2008) 752-760
30. Esterbauer H., Benedetti A., Lang J., Fulceri R., Fauler G., and Comporti M. Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim. Biophys. Acta. 876 (1986) 154-166
31. Gil-Núñez A. The metabolic syndrome and cerebrovascular disease: suspicion and evidence. Cerebrovasc. Dis. 24 (2007) S64-75
32. Girotti A.W. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J. Lipid. Res. 39 (1998) 1529-1542
33. Go Y.M., Halvey P.J., Hansen J.M., Reed M., Pohl J., and Jones D.P. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am. J. Pathol. 171 (2007) 1670-1681
34. Goodman Y., and Mattson M.P. Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp. Neurol. 128 (1994) 1-12
35. Götz J., and Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 9 (2008) 532-544
36. Grattagliano I., Palmieri V.O., Portincasa P., Moschetta A., and Palasciano G. Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J. Nutr. Biochem. 19 (2008) 491-504
37. Grimsrud P.A., Picklo Sr. M.J., Griffin T.J., and Bernlohr D.A. Carbonylation of adipose proteins in obesity and insulin resistance. identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell Proteomics 6 (2007) 624-637
38. Guiotto A., Calderan A., Ruzza P., and Borin G. Carnosine and carnosine-related antioxidants: a review. Curr. Med. Chem. 12 (2005) 2293-2315
39. Guo Z., Ersoz A., Butterfield D.A., and Mattson M.P. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. J. Neurochem. 75 (2000) 314-320
40. Haber C.A., Lam T.K., Yu Z., Gupta N., Goh T., Bogdanovic E., Giacca A., and Fantus I.G. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E744-E753
41. Halagappa V.K., Guo Z., Pearson M., Matsuoka Y., Cutler R.G., Laferla F.M., and Mattson M.P. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 26 (2007) 212-220
42. Harrell J.S., Jessup A., and Greene N. Changing our future: obesity and the metabolic syndrome in children and adolescents. J. Cardiovasc. Nurs. 21 (2006) 322-330
43. Herbst U., Toborek M., Kaiser S., Mattson M.P., and Hennig B. 4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells. J. Cell. Physiol. 181 (1999) 295-303
44. Hoff H.F., O'Neil J., Chisolm III G.M., Cole T.B., Quehenberger O., Esterbauer H., and Jürgens G. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. Arteriosclerosis 9 (1989) 538-549
45. Horsburgh K., McCulloch J., Nilsen M., McCracken E., Large C., Roses A.D., and Nicoll J.A. Intraventricular infusion of apolipoprotein E ameliorates acute neuronal damage after global cerebral ischemia in mice. J. Cereb. Blood Flow. Metab. 20 (2000) 458-462
46. Howard B.V., Ruotolo G., and Robbins D.C. Obesity and dyslipidemia. Endocrinol. Metab. Clin. North. Am. 32 (2003) 855-867
47. Huse D.M., Schulman K., Orsini L., Castelli-Haley J., Kennedy S., and Lenhart G. Burden of illness in Parkinson's disease. Mov. Disord. 20 (2005) 1449-1454
48. Hyun D.H., Emerson S.S., Jo D.G., Mattson M.P., and de Cabo R. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc. Natl. Acad. Sci. USA 103 (2006) 19908-19912
49. Ichiki T. Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both? Arterioscler Thromb. Vasc. Biol. 26 (2006) 449-455
50. Ishikawa T., Esterbauer H., and Sies H. Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. J. Biol. Chem. 261 (1986) 1576-1581
51. Jiang W.J. Sirtuins: novel targets for metabolic disease in drug development. Biochem. Biophys. Res. Commun. 373 (2008) 341-344
52. Jo, D.G., Arumugam, T.V., Woo, H.N., Park, J.S., Tang, S.C., Mughal, M., Hyun, D.H., Park, J.H., Choi, Y.H., Gwon, A.R., Camandola, S., Cheng, A., Cai, H., Song, W., Markesbery, W.R., Mattson, M.P., 2008. Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease. Neurobiol. Aging. 2008 Aug 5 (Epub ahead of print).
53. Johnson J.B., Summer W., Cutler R.G., Martin B., Hyun D.H., Dixit V.D., Pearson M., Nassar M., Telljohann R., Maudsley S., Carlson O., John S., Laub D.R., and Mattson M.P. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic. Biol. Med. 42 (2007) 665-674
54. Kakishita H., and Hattori Y. Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sci. 69 (2001) 689-697
55. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., and Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69 (1997) 273-284
56. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., and Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18 (1998) 687-697
57. Kelly J.F., Furukawa K., Barger S.W., Rengen M.R., Mark R.J., Blanc E.M., Roth G.S., and Mattson M.P. Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. USA 93 (1996) 6753-6758
58. Koçak G., Aktan F., Canbolat O., Ozoǧul C., Elbeǧ S., Yildizoglu-Ari N., Karasu C., and ADIC Study Group-Antioxidants in Diabetes-Induced Complications. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr. Metab. 13 (2000) 308-318
59. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., and Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17 (1997) 5089-5100
60. Lastra G., Manrique C., and Sowers J.R. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv. Chronic Kidney Dis. 13 (2006) 365-373
61. Lauderback C.M., Kanski J., Hackett J.M., Maeda N., Kindy M.S., and Butterfield D.A. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res. 924 (2002) 90-97
62. Lawler J.M., Kwak H.B., Kim J.H., and Suk M.H. Exercise training inducibility of MnSOD protein expression and activity is retained while reducing prooxidant signaling in the heart of senescent rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296 (2009) R1496-R1502
63. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., Lee V.M., Hersh L.B., Sapolsky R.M., Mirnics K., and Sisodia S.S. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120 (2005) 701-713
64. Lee J.H., Jung K.J., Kim J.W., Kim H.J., Yu B.P., and Chung H.Y. Suppression of apoptosis by calorie restriction in aged kidney. Exp. Gerontol. 39 (2004) 1361-1368
65. Leonarduzzi G., Chiarpotto E., Biasi F., and Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res. 49 (2005) 1044-1049
66. Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochem. Soc. Trans. 36 (2008) 343-347
67. Li Y., Perry T., Kindy M.S., Harvey B.K., Tweedie D., Holloway H.W., Powers K., Shen H., Martin B., Egan J., Lahiri D.K., Mattson M.P., Hoffer B.J., Wang Y., and Grieg N.H. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc. Natl. Acad. Sci. USA 106 (2009) 1285-1290
68. Lin S., Rhodes P.G., Lei M., Zhang F., and Cai Z. Alpha-Phenyl-n-tert-butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain. Brain Res. 1007 (2004) 132-141
69. Liu W., Akhand A.A., Kato M., Yokoyama I., Miyata T., Kurokawa K., Uchida K., and Nakashima I. 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J. Cell Sci. 112 (1999) 2409-2417
70. Lovell M.A., Ehmann W.D., Mattson M.P., and Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18 (1997) 457-461
71. 2+ channels in neurons by increasing protein tyrosine phosphorylation. J. Biol. Chem. 277 (2002) 24368-24375
72. Lyn-Cook Jr. L.E., Lawton M., Tong M., Silbermann E., Longato L., Jiao P., Mark P., Wands J.R., Xu H., and de la Monte S.M. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis. J. Alzheimers Dis. 16 (2009) 715-729
73. Mark R.J., Pang Z., Geddes J.W., Uchida K., and Mattson M.P. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17 (1997) 1046-1054
74. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., and Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 68 (1997) 255-264
75. Markesbery W.R., and Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19 (1998) 33-36
76. Martin B., Golden E., Keselman A., Stone M., Mattson M.P., Egan J.M., and Maudsley S. Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body. Histol. Histopathol. 23 (2008) 237-250
77. Martin, B., Golden, E., Carlson, O.D., Pistell, P., Zhou, J., Kim, W., Frank, B.P., Thomas, S., Chadwick, W.A., Greig, N.H., Bates, G.P., Sathasivam, K., Bernier, M., Maudsley, S., Mattson, M.P., Egan, J.M., 2008b. Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies and extends survival in a mouse model of Huntington's disease. Diabetes 2008 Nov 4 (Epub ahead of print).
78. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
79. Mattson M.P., Duan W., Wan R., and Guo Z. Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx (Neurotherapeutics). 1 (2004) 111-116
80. Mattson M.P., and Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J. Nutr. Biochem. 16 (2005) 129-137
81. Mattson M.P. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid. Redox Signal. 8 (2006) 1997-2006
82. Mattson M.P., and Cheng A. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 29 (2006) 632-639
83. Mattson M.P., and Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7 (2006) 278-294
84. Mattson M.P. Awareness of hormesis will enhance future research in basic and applied neuroscience. Crit. Rev. Toxicol. 38 (2008) 633-639
85. Mattson M.P. Dietary factors, hormesis and health. Ageing Res Rev. 7 (2008) 43-48
86. McKracken E., Graham D.I., Nilsen M., Stewart J., Nicoll J.A., and Horsburgh K. 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 11 (2001) 414-421
87. Morquette B., Shi Q., Lavigne P., Ranger P., Fernandes J.C., and Benderdour M. Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation. Arthritis Rheum. 54 (2006) 271-281
88. Morris R.T., Laye M.J., Lees S.J., Rector R.S., Thyfault J.P., and Booth F.W. Exercise-induced attenuation of obesity, hyperinsulinemia, and skeletal muscle lipid peroxidation in the OLETF rat. J. Appl. Physiol. 104 (2008) 708-715
89. Nishida Y., Yokota T., Takahashi T., Uchihara T., Jishage K., and Mizusawa H. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem. Biophys. Res. Commun. 350 (2006) 530-536
90. Okun E., Arumugam T.V., Tang S.C., Gleichmann M., Albeck M., Sredni B., and Mattson M.P. The organotellurium compound ammonium trichloro(dioxoethylene-0, 0') tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice. J. Neurochem. 102 (2007) 1232-1241
91. Parachikova A., Nichol K.E., and Cotman C.W. Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol. Dis. 30 (2008) 121-129
92. Pasinetti G.M., and Eberstein J.A. Metabolic syndrome and the role of dietary lifestyles in Alzheimer's disease. J. Neurochem. 106 (2008) 1503-1514
93. Pawlas N., and Małecki A. Effects of ebselen on glutathione level in neurons exposed to arachidonic acid and 4-hydroxynonenal during simulated ischemia in vitro. Pharmacol. Rep. 59 (2007) 708-714
94. Pedersen W.A., Chan S.L., and Mattson M.P. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 74 (2000) 1426-1433
95. Pennathur S., and Heinecke J.W. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid. Redox Signal. 9 (2007) 955-969
96. Perluigi M., Fai Poon H., Hensley K., Pierce W.M., Klein J.B., Calabrese V., De Marco C., and Butterfield D.A. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 38 (2005) 960-968
97. Petersen D.R., and Doorn J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med. 37 (2004) 937-945
98. Poli G., Schaur R.J., Siems W.G., and Leonarduzzi G. 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 28 (2008) 569-631
99. Pope S.K., Shue V.M., and Beck C. Will a healthy lifestyle help prevent Alzheimer's disease?. Annu. Rev. Public Health 24 (2003) 111-132
100. Refolo L.M., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G.S., Sambamurti K., Duff K., and Pappolla M.A. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7 (2000) 321-331
101. Russell A.P., Gastaldi G., Bobbioni-Harsch E., Arboit P., Gobelet C., Dériaz O., Golay A., Witztum J.L., and Giacobino J.P. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?. FEBS Lett. 551 (2003) 104-106
102. Sarafidis P.A., and Ruilope L.M. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am. J. Nephrol. 26 (2006) 232-244
103. Sayre L.M., Zelasko D.A., Harris P.L., Perry G., Salomon R.G., and Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68 (1997) 2092-2097
104. Schneider C., Porter N.A., and Brash A.R. Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J. Biol. Chem. 283 (2008) 15539-15543
105. Sejvar J.J., Holman R.C., Bresee J.S., Kochanek K.D., and Schonberger L.B. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology 25 (2005) 144-152
106. Sena C.M., Nunes E., Gomes A., Santos M.S., Proença T., Martins M.I., and Seiça R.M. Supplementation of coenzyme Q10 and alpha-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr. Res. 28 (2008) 113-121
107. Singh S.P., Niemczyk M., Saini D., Awasthi Y.C., Zimniak L., and Zimniak P. Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 47 (2008) 3900-3911
108. Singh S.P., Niemczyk M., Zimniak L., and Zimniak P. Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE). Aging 1 (2009) 68-80
109. Singhal S.S., Yadav S., Roth C., and Singhal J. RLIP76: a novel glutathione-conjugate and multi-drug transporter. Biochem. Pharmacol. 77 (2009) 761-769
110. Singleton J.R., and Smith A.G. Therapy insight: neurological complications of prediabetes. Nat. Clin. Pract. Neurol. 2 (2006) 276-282
111. Siow R.C., Ishii T., and Mann G.E. Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway. Redox Rep. 12 (2007) 11-15
112. Soh Y., Jeong K.S., Lee I.J., Bae M.A., Kim Y.C., and Song B.J. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Mol. Pharmacol. 58 (2000) 535-541
113. Srivastava S., Chandra A., Ansari N.H., Srivastava S.K., and Bhatnagar A. Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal. Biochem. J. 329 (1998) 469-475
114. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., and Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 11 (2008) 309-317
115. Stranahan, A.M., Lee, K., Martin, B., Maudsley, S., Golden, E., Cutler, R.G., Mattson, M.P., 2009. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus. 2009 Mar 11 (Epub ahead of print).
116. Surh Y.J., Kundu J.K., and Na H.K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 74 (2008) 1526-1539
117. Sutherland J.P., McKinley B., and Eckel R.H. The metabolic syndrome and inflammation. Metab. Syndr. Relat. Disord. 2 (2004) 82-104
118. Takizawa S., Matsushima K., Shinohara Y., Ogawa S., Komatsu N., Utsunomiya H., and Watanabe K. Immunohistochemical localization of glutathione peroxidase in infarcted human brain. J. Neurol. Sci. 122 (1994) 66-73
119. Tamagno E., Guglielmotto M., Aragno M., Borghi R., Autelli R., Giliberto L., Muraca G., Danni O., Zhu X., Smith M.A., Perry G., Jo D.G., Mattson M.P., and Tabaton M. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J. Neurochem. 104 (2008) 683-695
120. Tang S.C., Arumugam T.V., Cutler R.G., Jo D.G., Magnus T., Chan S.L., Mughal M.R., Telljohann R.S., Nassar M., Ouyang X., Calderan A., Ruzza P., Guiotto A., and Mattson M.P. Neuroprotective actions of a histidine analogue in models of ischemic stroke. J. Neurochem. 101 (2007) 729-736
121. Tang S.C., Lathia J.D., Selvaraj P.K., Jo D.G., Mughal M.R., Cheng A., Siler D.A., Markesbery W.R., Arumugam T.V., and Mattson M.P. Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Exp. Neurol. 213 (2008) 114-121
122. Towfighi A., and Ovbiagele B. Metabolic syndrome and stroke. Curr. Diab. Rep. 8 (2008) 37-41
123. Urabe T., Yamasaki Y., Hattori N., Yoshikawa M., Uchida K., and Mizuno Y. Accumulation of 4-hydroxynonenal-modified proteins in hippocampal CA1 pyramidal neurons precedes delayed neuronal damage in the gerbil brain. Neuroscience 100 (2000) 241-250
124. VanWinkle W.B., Snuggs M., Miller J.C., and Buja L.M. Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal. Cell Motil. Cytoskeleton. 28 (1994) 119-134
125. Vincent H.K., Powers S.K., Dirks A.J., and Scarpace P.J. Mechanism for obesity-induced increase in myocardial lipid peroxidation. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 378-388
126. Vincent H.K., Innes K.E., and Vincent K.R. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes. Metab. 9 (2007) 813-839
127. Vistoli G., Orioli M., Pedretti A., Regazzoni L., Canevotti R., Negrisoli G., Carini M., and Aldini G. Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species. Chem. Med. Chem. 4 (2009) 967-975
128. Williams T.I., Lynn B.C., Markesbery W.R., and Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol. Aging 27 (2006) 1094-1099
129. Wonisch W., Zellnig G., Kohlwein S.D., Schaur R.J., Bilinski T., Tatzber F., and Esterbauer H. Ultrastructural analysis of HNE-treated Saccharomyces cerevisiae cells reveals fragmentation of the vacuole and an accumulation of lipids in the cytosol. Cell Biochem. Funct. 19 (2001) 59-64
130. Xiao C., Giacca A., and Lewis G.F. Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia 51 (2008) 139-146
131. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., and Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84 (1989) 1086-1095
132. Yun M.R., Im D.S., Lee S.J., Woo J.W., Hong K.W., Bae S.S., and Kim CD. 4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class A scavenger receptor at the level of translation. Free Radic. Biol. Med. 45 (2008) 177-183
133. Zarrouki B., Soares A.F., Guichardant M., Lagarde M., and Géloën A. The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett. 581 (2007) 2394-2400
134. Zhu H., Guo Q., and Mattson M.P. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res. 842 (1999) 224-229